Alison Hayles
About Alison Hayles
Alison Hayles is the Vice President, Head Global Regulatory Strategy at BeiGene, with over 25 years of experience in regulatory affairs, particularly in oncology.
Current Position at BeiGene
Alison Hayles currently holds the position of Vice President, Head Global Regulatory Strategy at BeiGene in the United States. She assumed this role in August 2023, bringing with her over 25 years of experience in regulatory affairs, particularly in the oncology therapeutic area. Her responsibilities at BeiGene likely include overseeing global regulatory strategies, ensuring compliance with international regulatory requirements, and guiding the company through complex regulatory pathways.
Previous Roles at Astellas Pharma
Before joining BeiGene, Alison Hayles worked at Astellas Pharma in various high-level positions. Most recently, she served as Vice President RA, Oncology TA Head from 2020 to 2023. Prior to that, she was the Executive Director Global Regulatory Affairs, Oncology TA Head from 2015 to 2020. She also held positions such as Senior Director Regulatory Affairs Oncology and Director, Regulatory Affairs Oncology during her tenure at Astellas Pharma. Her roles at Astellas encompassed strategic leadership in regulatory affairs, with a focus on oncology.
Experience at Takeda Pharmaceuticals
Alison Hayles spent a year at Takeda Pharmaceuticals, working as Manager/Senior Manager, Regulatory Affairs Oncology from 2007 to 2008. In this position, she was responsible for regulatory activities related to oncology products, ensuring that they met all applicable regulatory standards. Her contributions at Takeda significantly enhanced her expertise in the oncology regulatory landscape.
Career Overview at Abbott Laboratories
Alison Hayles spent a decade at Abbott Laboratories, where she advanced from Regulatory Affairs Associate to Manager from 1997 to 2007. This period was foundational to her career, providing her with extensive knowledge and experience in regulatory affairs. At Abbott Laboratories, she gained a thorough understanding of regulatory processes, compliance, and strategic planning, which paved the way for her future leadership roles in the pharmaceutical industry.
Expertise in Global Regulatory Strategy
Alison Hayles has extensive expertise in global regulatory strategy, particularly in the oncology therapeutic area. Over her 25-year career, she has held multiple leadership positions across various pharmaceutical companies, including BeiGene, Astellas Pharma, Takeda Pharmaceuticals, and Abbott Laboratories. Her experience encompasses the development and implementation of regulatory strategies, compliance with international regulatory standards, and navigating complex regulatory environments to bring oncology products to market efficiently.